Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Gastric Cancer / Gastric adenocarcinoma / Stomach cancer & ST6GalNAc I sialyltransferase (ST6GALNAC1)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Expression of STn was almost negative in human gastric cancer cell lines MKN74, NUGC4, KATOIII cells
Tamura et al., 2016

Five-year survival rates of patients with STN-positive cancers (47.2%) were significantly lower than those with STN-negative cancers (84.4%)
Ma et al. 1993

The Sialyl-Tn (STn) / Neu5Acα2-6GalNAc-O-Ser/Thr expression occurred in 53 (62.4%) cancers
Ma et al. 1993
…

References (Sources)

Expression of sialyl-Tn antigen is correlated with survival time of patients with gastric carcinomas
Ma et al. 1993
RNAi-mediated gene silencing of ST6GalNAc I suppresses the metastatic potential in gastric cancer cells
Tamura et al., 2016

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!

Gastric Cancer / Gastric adenocarcinoma / Stomach cancer & ST6GalNAc I sialyltransferase (ST6GALNAC1)

Welcome to meRfi Microbiome!

Navigation

Contents

References (Sources)

AI Chat